Partner with Us to Redefine Healthcare Safety

KODA Ideaworks is actively seeking strategic partners, institutional investors, and aligned acquirers to help scale the next generation of surgical safety. Our flagship product, HypoHolder, is a patented, safety-engineered, FDA-registered, one-handed safety solution that reduces the most dangerous, and costly, hypodermic needle handling injuries in healthcare. With growing demand from surgical teams, VA systems, and military buyers, we’re ready to scale.

Invest in the Future of Hypodermic Needle Safety

  • HypoHolder, KODA's flagship product, is a one-handed FDA-cleared safety engineered medical device that reduces hypodermic needlestick injuries
  • Funds will support inventory, IP, sales, clinical trials, R&D, injection molding, and military-grade supply chain expansion
  • Backed by $1M+ in pre-seed SAFE and grant funding, with a targeting close before Q1 2026
  • Manufacturing partnerships in place (civilian & military)
  • Active DoD trial discussions underway
How can I access my medical records?
What if I have a medical emergency after hours?
Do you provide vaccination services?

Validated, Funded & Ready to Scale Globally

  • FDA-Registered Class I Exempt Medical Device
  • 815+ Surgical Contacts with research trials beginning
  • Growing Demand in civilian and government systems
  • Military Trials in active planning
  • Commercial traction without a traditional sales force
  • Designed by clinicians with 70+ years of OR experience
How can I access my medical records?
What if I have a medical emergency after hours?
Do you provide vaccination services?
General consultation -
Family medicine -
General consultation -
Family medicine -
General consultation -
Family medicine -
Women’s health _
expert advice
Women’s health _
expert advice
Women’s health _
expert advice

See HypoHolder in Action

Interested in learning more?

KODA Ideaworks hosts virtual investor meetings throughout the year. Contact us to receive our pitch materials or join an upcoming investor session.

Discover more
Discover more
Contact Us